Description: Foretinib / XL880 / GSK1363089, is an orally bioavailable small molecule with potential antineoplastic activity. MET/VEGFR2 inhibitor GSK1363089 binds to and selectively inhibits hepatocyte growth factor (HGF) receptor c-MET and vascular endothelial growth factor receptor 2 (VEGFR2), which may result in the inhibition of tumor angiogenesis, tumor cell proliferation and metastasis.
Catalog | OFC849217647 |
CAS | 849217-64-7 |
Category | Fluorinated APIs |
Synonyms | XL880 |
Purity | >98% |
※ Please kindly note that our products are for research use only.
IUPAC Name | 1-N'-[3-fluoro-4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide |
InChI | InChI=1S/C34H34F2N4O6/c1-43-30-20-25-27(21-31(30)45-16-2-13-40-14-17-44-18-15-40)37-12-9-28(25)46-29-8-7-24(19-26(29)36)39-33(42)34(10-11-34)32(41)38-23-5-3-22(35)4-6-23/h3-9,12,19-21H,2,10-11,13-18H2,1H3,(H,38,41)(H,39,42) |
InChI Key | CXQHYVUVSFXTMY-UHFFFAOYSA-N |
Isomeric SMILES | COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F |
EC Number | 629-893-0 |
Molecular Formula | C34H34F2N4O6 |
Molecular Weight | 632.65 |
Appearance | White to off-white solid powder |
XLogP3-AA | 5.5 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 12 |
Exact Mass | 632.24464114 g/mol |
Monoisotopic Mass | 632.24464114 g/mol |
Topological Polar Surface Area | 111Ų |
Heavy Atom Count | 46 |
Formal Charge | 0 |
Complexity | 1010 |
Please kindly note that our products and services are for research use only.